These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2541744)

  • 1. Undifferentiated carcinoma of nasopharyngeal type of tonsil.
    Klijanienko J; Micheau C; Azli N; Cvitkovic E; Eschwege F; Marandas P; Armand JP; Casiraghi O; Schwaab G; de Vathaire F
    Arch Otolaryngol Head Neck Surg; 1989 Jun; 115(6):731-4. PubMed ID: 2541744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The significance of serologic test for EB-virus antibody in occult type nasopharyngeal carcinoma.
    Furukawa M; Takimoto T; Morishita K; Komori T; Ishiguro H; Umeda R
    Auris Nasus Larynx; 1983; 10(1):43-8. PubMed ID: 6311149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of anti-Epstein-Barr virus antibodies in nasopharyngeal carcinoma (NPC).
    Liu MT; Yeh CY
    Radiat Med; 1998; 16(2):113-7. PubMed ID: 9650898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Titers of Epstein-Barr virus-related antibodies in nasopharyngeal carcinoma in Japan.
    Tamada A; Makimoto K; Yamabe H; Imai J; Hinuma Y; Oyagi A; Araki T
    Cancer; 1984 Feb; 53(3):430-40. PubMed ID: 6318948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, tonsillar carcinoma and control groups.
    Oberender H; Nowak R; Donner A; Kunkel M; Gärtner L; Scholtz HJ
    Acta Virol; 1983 May; 27(3):277-81. PubMed ID: 6138990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-Epstein Barr virus antibody in nasopharyngeal carcinoma.
    Hsu MM; Chiou JF; McCabe BF
    Ann Otol Rhinol Laryngol; 1974; 83(1):19-25. PubMed ID: 4359674
    [No Abstract]   [Full Text] [Related]  

  • 7. [Epstein-Barr virus--a clinically relevant feature of nasopharyngeal carcinoma? (author's transl)].
    Wilmes E; Wolf H; Deinhardt F; Naumann HH
    Laryngol Rhinol Otol (Stuttg); 1981 Jan; 60(1):4-6. PubMed ID: 6261051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Value of anti-Epstein-Barr antibody detection in the diagnosis and management of undifferentiated carcinoma of the nasopharynx].
    Mazeron MC
    Bull Cancer Radiother; 1996; 83(1):3-7. PubMed ID: 8679277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The capsid antigen of Epstein-Barr virus in nasopharyngeal carcinomas: comparison of serum antibody titre, cellular antigen content and histopathology.
    Falser N
    Arch Otorhinolaryngol; 1984; 239(1):15-23. PubMed ID: 6318710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective evaluation of patients with nasopharyngeal carcinoma: an overview.
    Neel HB
    J Otolaryngol; 1986 Jun; 15(3):137-44. PubMed ID: 3014165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Tonsillar cancer and Epstein-Barr virus].
    Wilmes E; Wolf H; Haus M
    Laryngol Rhinol Otol (Stuttg); 1983 Dec; 62(12):586-9. PubMed ID: 6323895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association between carcinoma of the tonsil and Epstein-Barr virus--a study using radiolabelled in situ hybridization.
    Nicholls JM; Pittaluga S; Chung LP; So KC
    Pathology; 1994 Apr; 26(2):94-8. PubMed ID: 8090602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus and carcinomas: undifferentiated carcinomas but not squamous cell carcinomas of the nasopharynx are regularly associated with the virus.
    Niedobitek G; Hansmann ML; Herbst H; Young LS; Dienemann D; Hartmann CA; Finn T; Pitteroff S; Welt A; Anagnostopoulos I
    J Pathol; 1991 Sep; 165(1):17-24. PubMed ID: 1659626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus-specific serodiagnostic tests in carcinomas of the head and neck.
    Ringborg U; Henle W; Henle G; Ingimarsson S; Klein G; Silfversward C; Strander H
    Cancer; 1983 Oct; 52(7):1237-43. PubMed ID: 6309355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus antibodies in tonsillar carcinoma patients;
    Vonka V; Sibl O; Suchánková A; Simonová I; Závadová H
    Int J Cancer; 1977 Apr; 19(4):456-9. PubMed ID: 191412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human nasopharyngeal carcinomas positive for Epstein-Barr virus DNA in North America.
    Glaser R; Nonoyama M; Szymanowski RT; Graham W
    J Natl Cancer Inst; 1980 Jun; 64(6):1317-9. PubMed ID: 6246300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term follow-up of IgG and IgA antibodies against viral capsid antigens of Epstein-Barr virus in nasopharyngeal carcinoma.
    Lynn TC; Tu SM; Kawamura A
    J Laryngol Otol; 1985 Jun; 99(6):567-72. PubMed ID: 2989398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunoglobulin A serum antibodies against the capsid antigen of Epstein-Barr virus in the differential diagnosis and follow-up of nasopharyngeal cancer].
    Pavelka R; Popow-Kraupp T; Radaszkiewicz T
    Wien Klin Wochenschr; 1985 Jul; 97(14):588-95. PubMed ID: 2996246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The role of Epstein-Barr virus (EBV) infection in carcinogenesis of palatine tonsil carcinoma (PTC)].
    Kruk-Zagajewska A; Szkaradkiewicz A; Wierzbicka M; Jopek A; Woźniak A
    Otolaryngol Pol; 2001; 55(3):267-72. PubMed ID: 11765441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between the Epstein-Barr virus genome and nasopharyngeal carcinoma in Caucasian patients.
    Andersson-Anvret M; Forsby N; Klein G; Henle W; Biörklund A
    Int J Cancer; 1979 Jun; 23(6):762-7. PubMed ID: 223991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.